These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 33928086)

  • 1. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
    Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
    Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Pan J; Huang Z; Xu Y
    Front Oncol; 2021; 11():657466. PubMed ID: 34195072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma.
    Nie F; Jiang J; Ning J
    Medicine (Baltimore); 2024 Jun; 103(25):e38623. PubMed ID: 38905403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
    Pan W; Liu X; Liu S
    Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the expression and prognostic significance of m
    Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
    Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
    Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X
    Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
    Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
    Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
    Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
    BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of m
    Fang X; Miao C; Zeng T; Chu W; Zheng Y; Sun X; Yin X; Li Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24303. PubMed ID: 35212022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
    Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
    J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization and Clinical Characteristics of m5C-Based RNA Methylation in Spinal Cord Injury: Validated by qPCR.
    Cao L; Pi WJ; Zhang Q; Li Q
    Int J Genomics; 2022; 2022():5433860. PubMed ID: 36582430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer.
    Huang Z; Li J; Chen J; Chen D
    Front Genet; 2021; 12():748279. PubMed ID: 34777473
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
    Geng Q; Wei Q; Shen Z; Zheng Y; Wang L; Xue W; Li L; Zhao J
    Cancer Manag Res; 2021; 13():7989-8002. PubMed ID: 34707405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer.
    Cao T; Huang M; Huang X; Tang T
    PeerJ; 2024; 12():e16935. PubMed ID: 38435998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel m6A/m5C/m1A/m7G-related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer.
    Chen R; Jiang L
    Transl Cancer Res; 2024 Jul; 13(7):3285-3298. PubMed ID: 39145046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.